Latest Stories

Don’t miss our hot and upcoming stories
FDA Qualifies First AI Drug Development Tool, Will Be Used in ‘MASH’ Clinical Trials to Accelerate Liver Disease Drug Development

The U.S. Food and Drug Administration (FDA) has qualified AIM-NASH, the first AI-based tool designed…

ByByAnuja Singh Dec 13, 2025
How Novartis and Relation Therapeutics’ $1.7 Billion AI Collaboration Redefine Drug Discovery Success Rates in Immunology, Atopic Diseases?

Key Highlights: • AI-driven, patient-derived target discovery emerges as a new gold standard for reducing…

ByByAnuja Singh Dec 13, 2025
How Roche’s $55 Million Bet on Manifold Bio’s AI Brain-Shuttle Platform Unlock the Next Trillion-Dollar Neuroscience Opportunity?

Key Highlights• Roche deepens its AI-first drug discovery strategy with a foundational partnership targeting blood-brain…

ByByAnuja Singh Dec 12, 2025
Will Lilly’s AI Supercomputer with NVIDIA Become the Breakthrough That Redefines Competitive Timelines in Drug Development?

• Lilly partners with NVIDIA to build what it calls the most powerful AI supercomputer…

ByByAnuja Singh Dec 6, 2025
Scroll to Top